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Abstract
Objective The objective of this work was to evaluate effects of a dentifrice containing sodium fluoride (1150 ppm F) and the
organic polyphosphate phytate (0.85% w/w of the hexa-sodium salt) on in situ remineralisation of early enamel erosive lesions
and resistance to subsequent demineralisation.
Materials and methods Subjects (n = 62) wore palatal appliances holding eight bovine enamel specimens with pre-formed
erosive lesions. They brushed their natural teeth with the phytate test dentifrice (TD); a positive control dentifrice (PC,
1150 ppm fluoride as NaF); a reference dentifrice (RD, disodium pyrophosphate + 1100 ppm fluoride as NaF) or a negative
control dentifrice (NC, fluoride-free) in a randomised, double-blind, crossover design. Specimens were removed at 2, 4 and 8 h
post-brushing and exposed to an ex vivo acid challenge. Surface microhardness (Knoop) was measured at each stage. The
primary efficacy variable was relative erosion resistance (RER); other variables included the surface microhardness recovery
(SMHR), acid resistance ratio (ARR) and enamel fluoride uptake (EFU).
Results After 4 h, the results for RER, ARR and EFU were in the order PC > TD = RD >NC with PC > TD = RD = NC for
SMHR. Results at 2 and 8 h were generally consistent with the 4 h data. Mineralisation progressed over time. Dentifrices were
generally well-tolerated.
Conclusions In this in situ model, addition of phytate or pyrophosphate to a fluoride dentifrice inhibited the remineralising effect
of fluoride. Both formulations still delivered fluoride to the enamel and inhibited demineralisation, albeit to a lesser extent than a
polyphosphate-free dentifrice.
Clinical relevance Addition of phytate or pyrophosphate to a fluoride dentifrice may reduce its net anti-erosive properties.
Keywords Dental erosion . Demineralisation . Dentifrice . Fluoride . Polyphosphate . Remineralisation
Introduction
Dental erosion is the loss of tooth substance due to chemical
dissolution by acids of non-bacterial origin [1], which causes
enamel to soften and become more susceptible to abrasive
wear [2, 3]. In the initial stages, the eroded enamel surface
can be repaired through replacement of lost mineral structure
by salivary calcium and phosphate [4, 5]. In a series of in situ
clinical studies, dentifrice formulations containing up to
1426 ppm fluoride as sodium fluoride (NaF) have been shown
to accelerate remineralisation and enhance acid resistance of
the enamel surface [6–8]. A significant dose–response for
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fluoride has been observed [7, 8]. Interestingly, certain denti-
frices were significantly less effective than others in terms of
promoting enamel remineralisation and erosion resistance,
even though fluoride concentrations were matched. This sug-
gests that non-fluoride ingredients in the dentifrice formula-
tion may modulate fluoride effects on the remineralisation and
demineralisation process [7].
Cosmetic benefits of dentifrice formulations are also im-
portant, particularly their ability to remove extrinsic tooth
stains. Whilst abrasives are almost universally added to den-
tifrices to achieve this, a balance must be reached between
adequate stain removal during toothbrushing and potential of
abrasives to increase wear of the dental hard tissues over the
lifetime of the tooth [9, 10]. An approach to improve stain
control without substantially increasing abrasivity is to in-
clude polyphosphate salts in the formulation [10, 11]. Linear
condensed polyphosphates bind to tooth surfaces and com-
plex calcium ions, interfering with the development and reten-
tion of extrinsic stains [11, 12], as well as dental calculus [13].
Whilst published long-term clinical studies suggest that
polyphosphates do not impair the anticaries benefits of fluo-
ride [14, 15], linear polyphosphates can inhibit the exchange
of mineral ions on the tooth surface, thereby interfering with
the ability of fluoride to remineralise eroded enamel [7, 16,
17].
Phytate (myo-inositol hexakis [dihydrogen phosphate]) is
an organic cyclic polyphosphate ion without direct phos-
phate–phosphate bonds. It is a potential alternative to
established inorganic linear condensed polyphosphates for
dentifrice applications. In vitro, phytate has been shown to
rapidly absorb onto hydroxyapatite and is a potent dissolution
inhibitor [18]. Phytate also modifies the permselectivity of
enamel and dentine, with potential benefits in terms of caries
progression [19]. In early animal caries studies, phytate was
shown to inhibit demineralisation and exhibit anticaries ef-
fects in the absence of fluoride [20]. Furthermore, a clinical
study of a phytate-containing mouthwash demonstrated that
phytate is able to reduce dental calculus formation [21], but
there is otherwise little recent published information on oral
applications of this molecule. The substantially different struc-
ture of phytate versus linear condensed polyphosphates may
mean it interacts with enamel surfaces in a different way, po-
tentially able to provide stain removal benefits without the
degree of influence on remineralisation processes.
The aim of this work was to investigate the influence of
phytate in a dentifrice on intra-oral enamel remineralisation
and subsequent resistance to demineralisation. An in situ clin-
ical study was performed to examine the effects of an exper-
imental fluoride dentifrice formulation containing phytate
(0.85% w/w) on (bovine) enamel remineralisation, enamel
fluoride uptake and resistance to acid challenge after a single
brushing. Performance was determined relative to a positive
control (fluoride but no phytate), a negative control (no
phytate or fluoride) and a reference dentifrice (containing
fluoride and an alternative polyphosphate). To make infer-
ences regarding potential differences in the time-course of
these effects, results were obtained after 2, 4 and 8 h of
intraoral exposure [22, 23].
Materials and methods
This was a single-centre, randomised, examiner- and ana-
lyst-blind, crossover study performed at the Oral Health
Research Institute (OHRI) of the Indiana University
School of Dentistry, Indianapolis, IN, USA. The protocol
was approved by the Indiana University Institutional
Review Board (IRB #1506930286), and the study was
conducted in accordance with the Declaration of
Helsinki, the International Conference on Harmonisation
of Techn ica l Requi rements fo r Reg is t r a t ion of
Pharmaceuticals for Human Use and local laws and regu-
lations. All subjects provided written informed consent
prior to screening, demonstrated understanding of the pro-
tocol and were considered willing, able and likely to com-
ply with all study procedures. There was one minor ad-
ministrative amendment to the protocol that did not affect
study flow or outcomes.
Study population
Subjects aged 18–65 years previously accepted into the
OHRI dental erosion in situ panel and for whom a palatal
appliance had been constructed were screened for this
study. Subjects were eligible for inclusion if they had an
unstimulated salivary flow rate of ≥ 0.2 mL/min and a
stimulated salivary flow rate of ≥ 0.8 mL/min; a maxillary
dental arch suitable for retention of the palatal appliance
and good general and oral health. Subjects were excluded
from participation if they were pregnant or breastfeeding;
had a medical history that could prevent them from par-
ticipating in the study until the study conclusion; had any
sign of grossly carious active lesions, moderate or severe
periodontal conditions, or severe tooth wear; wore an oral
appliance or orthodontia; were receiving any medication
that could interfere significantly with salivary flow; had
an intolerance or hypersensitivity to the study materials;
or had used any investigational products or participated in
another clinical trial within 30 days of the screening visit.
Study treatments
Details of study dentifrices are listed in Table 1.
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Experimental design
At the screening visit, subjects underwent examination of the
oral hard tissue and oral soft tissue (OST) and were assessed
for eligibility. Eligible subjects had their palatal appliance
fitted for comfort and were provided with a fluoride-free den-
tifrice to use for 2 days before each treatment visit. OST ex-
aminations were also performed at the beginning of each treat-
ment visit.
Subjects were instructed to follow their usual oral hygiene
habits over the course of the study, with the exception that
they were required to use the fluoride-free washout toothpaste
for 2 days before each visit and were not permitted to brush
their teeth or use any fluoride-containing products on the
morning of any visit. Subjects could eat breakfast on the
morning of each visit, as long as this was at least 30 min prior
to the visit.
At the baseline visit, eligible subjects were randomised
according to a schedule generated in advance by the
Biostatistics Department of GSK Consumer Healthcare.
Each subject completed all treatments in a random order,
one at each treatment visit. The study dentifrices were sup-
plied in over-wrapped tubes. The site personnel, study statis-
tician and other employees of the study site or sponsor who
had the potential to influence study outcomes were blinded to
product allocation.
At each of the four treatment visits, a study dentist placed
the subject’s palatal appliance holding the eight bovine tooth
enamel specimens in the subject’s mouth. After an equilibra-
tion period of at least 5 min, the subject was provided with a
toothbrush (Sensodyne® Soft; GSK Consumer Healthcare,
Weybridge, UK) loaded with 1.5 g of the assigned dentifrice.
A study technician instructed the subjects to brush the buccal
surfaces of their natural teeth for 25 timed seconds to create a
slurry, then swish the slurry around the palatal appliance for
1 min and 35 s (timed) to permit direct contact with the enamel
specimens. Subjects expectorated the slurry, then gently rinsed
with 15 mL of deionised water for 10 s and expectorated the
rinse.
After completing the brushing/rinsing procedures, subjects
continued to wear their palatal appliance for a total of 8 h, with
a single interruption of 30 min after 4 h, during which they
could eat a meal and drink bottled water (Ice Mountain®
Spring Water, Nestlé Waters North America Inc., Stamford,
CT, USA) (> 0.1 ppm F). Subjects were instructed to refrain
from talking for the first hour after brushing and were not
permitted to drink water for the first 2 h of the test period,
but they could drink water after this under the supervision of
study personnel. Subjects were not permitted to leave the
study site or sleep when the appliance was in their mouth.
Enamel specimens were removed in a predetermined order
from the appliance at 2 h (two specimens, one each from the
end of the left- and right-side specimen holder, respectively),
4 h (four specimens, two from the centre of each specimen
holder) and 8 h (remaining two specimens).
In situ erosion remineralisation model
This study used an in situ erosion–remineralisation model
developed by Zero et al. [6]. In brief, bovine enamel blocks
were polished flat and the enamel side of the specimen was
ground until the enamel surface had a minimum 3 × 3 mm
facet in the centre. The enamel specimens were immersed in
commercially available grapefruit juice for 25 min then rinsed
thoroughly with deionised water. Following sterilisation with
ethylene oxide, the demineralised enamel blocks were fixed to
a tailored intra-oral palatal appliance engineered to hold eight
specimens mounted on two plastic holders. The palatal appli-
ance was inserted into the subject’s mouth for 5 min prior to
treatment to allow a degree of pellicle formation. The appli-
ance remained in the subject’s mouth for 8 h following treat-
ment, with the enamel specimens removed at predefined in-
tervals as described above. After the specimens were removed
from the appliance, they underwent a second demineralisation
treatment using the procedure described above.
Changes in the mineral content of the enamel specimens
were evaluated using the surface microhardness (SMH) test
[6, 24, 25]. Five indentations were made in the centre of each
enamel specimen using a Knoop diamond (2100 HT; Wilson
Instruments). Indentation lengths were measured, and the
mean indentation length was calculated. Indentation lengths
were determined prior to the first in vitro erosive challenge
(B), after the first in vitro erosive challenge (E1), after the
treatment-induced in situ remineralisation phase (R) and after
the second in vitro erosive challenge (E2).
Table 1 Study treatments
Dentifrice Fluoridea
(ppm)
Phytateb
(% w/w)
KNO3
(% w/w)
Stain removal agents
Test 1150 0.85 5.0 Hydrated silica,
hexasodium phytate
Positive
controlc
1150 – 5.0 Hydrated silica
Referenced 1100 – – Hydrated silica,
disodium
pyrophosphate
Negative
control
– – 5.0 Hydrated silica
KNO3, potassium nitrate; ppm, parts per million; w/w, weight-for-weight
a As sodium fluoride (NaF)
b% w/w of hexasodium salt
c Sensodyne® Pronamel®—Mint Essence; GSK Consumer Healthcare,
Weybridge, UK (US-marketed dentifrice)
d Crest 3D White Luxe™ Glamorous White™; Procter & Gamble,
Cincinnati, OH, USA (US-marketed dentifrice)
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Data analysis
The extent of remineralisation was calculated as the percent
SMH recovery (%SMHR), based on the following formula:
%SMHR= [(E1-R) / (E1-B)] ∗ 100 [26].
Overall enamel resistance to erosive challenge was calcu-
lated as the percent relative erosion resistance (%RER) based
on the following formula: %RER = [(E1-E2) / (E1-B)] ∗ 100
[8, 27].
The acid resistance of the enamel specimens following
intra-oral exposure to the study dentifrices was calculated as
the acid resistance ratio (ARR) based on the following formu-
la: ARR = 1-[(E2-R) / (E1-B)] (based on Creeth et al. [8]).
Enamel fluoride uptake (EFU) during the remineralisation
phase was determined using the microdrill enamel biopsy
technique following the in situ remineralisation phase and
SMHR test and before the second in vitro erosive challenge
[28]. Enamel specimens were drilled to a depth of approxi-
mately 100 μm through the entire lesion (four cores per spec-
imen). EFU was expressed as μg F per cm2 of enamel surface.
These analyses were performed on the enamel specimens
after 2, 4 and 8 h of intra-oral remineralisation. An exploratory
analysis was performed to determine whether any change with
time in the SMHR, RER, ARR or EFU endpoints was a func-
tion of treatment: this was called the Btime-by-treatment^
analysis.
Safety
Adverse events (AEs) and any abnormalities in the OST ex-
amination were recorded from the start of the study period
until 5 days after the last administration of study product.
Clinical judgement was exercised by the investigator to diag-
nose the AE and to assess the relationship between the study
product and the occurrence of each AE, with intensity graded
as mild, moderate or severe.
Statistical analysis
This study aimed to recruit up to 62 subjects to ensure
that at least 56 subjects completed all study visits. This
sample was calculated to have 80% power to detect a
difference in %RER of approximately 10.7 between prod-
ucts, assuming two-sided paired tests at a 5% significance
level. A difference of 10.7 in %RER was considered as
modest to be detected between not only the Test dentifrice
and fluoride-free Negative control but also between
Positive control and Reference formulations containing
fluoride. In a study of similar design, the standard devia-
tion (SD) for the difference between a test dentifrice and a
reference dentifrice was 28.4 for %RER [8].
Analysis of covariance (ANCOVA) was used to analyse
the primary efficacy variable (%RER) and the other secondary
response variables. The ANCOVA model included a random
effect for subject and fixed effects for study period and treat-
ment with subject- and period-level baseline, and subject and
period level pre-treatment covariates. Pair-wise comparisons
between the treatments on all endpoints were performed. All
tests were two-sided at a 5% significance level.
The exploratory endpoint (differences in the time-course of
remineralisation between treatments on %RER, %SMHR,
ARR and EFU) was analysed using an ANCOVA model with
%RER, %SMHR, ARR and EFU as dependent variables,
fixed effect as treatment, period, time of extraction and a
time-by-treatment interaction as fixed effect and subject as
random effect. Baseline and pre-treatment acid challenge
values were included as covariates.
Efficacy analyses were conducted on the per-protocol (PP)
population, defined as all subjects who were randomised into
the study, received at least one dose of study product, had at
least one post-baseline efficacy assessment and had no proto-
col violations deemed to affect efficacy during the study. The
intent-to-treat (ITT) population was defined as all subjects
whowere randomised into the study, received at least one dose
of study product and had at least one post-baseline efficacy
assessment. Efficacy analyses were also to be performed on
the ITT population if there was more than a 10% difference in
the number of subjects in the ITT and PP populations. The
safety population included all randomised subjects that were
dispensed the study treatment at least once during the study.
Results
Subjects
The first subject was enrolled on 24 August 2015, and the last
subject completed the study on 18 November 2015. Of the 72
Fig. 1 Subject flow diagram. ITT, intent-to-treat; PP, per-protocol
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subjects screened, 62 were randomised to treatment and 60
completed the study (Fig. 1). All randomised subjects were
included in the ITT and safety populations. Subjects were
aged 19 to 63 years (mean 41.0; SD 11.35), and 67.7% were
female. The majority of subjects were white (62.9%), with
30.6% identifying as black/African American and 6.5% as
Asian.
Efficacy
The raw mean SMH values for the enamel specimens at each
stage of the different treatments are summarised in Table 2.
RER
Adjusted mean %RER (± standard error [SE]) at 2, 4 and 8 h
for each dentifrice is shown in Fig. 2. At the 4-h time point
(see Table 3, showing treatment differences, 95% confidence
intervals [CI] and p value), the RER value for the experimen-
tal phytate formulation (Test dentifrice) was higher than that
of the Negative control by 18.4 percentage points
(p < 0.0001), but there was no significant difference between
the Test and Reference dentifrices. The RER values for the
Positive control were 45.1 and 26.7 percentage points higher
than those of the Negative control and Test dentifrice, res-
pectively (both p < 0.0001). The RER for the Reference
Table 2 Enamel microhardness mean indent lengths (μm, ± standard error) as a function of treatment, stage of the experiment, and duration of
remineralisation
Time point Treatment No. of subjects B E1 R E2
Mean indent
length
S.E. Mean indent
length
S.E. Mean indent
length
S.E. Mean indent
length
S.E.
2 h Test 62 43.42 0.100 60.06 0.217 57.66 0.232 69.90 0.341
Positive control 62 43.30 0.108 59.93 0.185 55.87 0.212 64.92 0.411
Reference 61 43.42 0.113 59.88 0.232 57.97 0.209 70.21 0.339
Negative control 62 43.26 0.120 60.27 0.196 57.72 0.220 73.84 0.408
4 h Test 62 43.38 0.101 60.12 0.181 57.13 0.195 69.38 0.288
Positive control 62 43.24 0.107 59.98 0.182 55.45 0.187 64.86 0.269
Reference 60 43.37 0.102 59.86 0.180 57.38 0.204 69.42 0.297
Negative control 62 43.23 0.106 59.87 0.181 56.94 0.209 72.25 0.398
8 h Test 62 43.41 0.098 60.06 0.224 56.41 0.247 67.80 0.342
Positive control 62 43.32 0.117 59.99 0.242 54.27 0.238 63.81 0.333
Reference 60 43.30 0.130 60.00 0.257 56.74 0.235 68.70 0.361
Negative control 62 43.17 0.124 59.70 0.224 56.08 0.249 70.14 0.408
Fig. 2 Percent relative acid
resistance (%RER) versus
specimen removal time (adjusted
means ± standard error). Data for
the Reference dentifrice are offset
for clarity
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dentifrice was significantly higher than that of the Negative
control dentifrice (p < 0.0001).
Similar differences and statistical significances were also
demonstrated at 2 and 8 h post intra-oral exposure except that
the difference in RER for the Test dentifrice versus the
Reference dentifrice became statistically significant (p =
0.0444) after 8 h exposure.
There was a consistent upward trend for the %RER values
as a function of time for all treatments. There was no indica-
tion that the rate of rise was a function of treatment: the time-
by-treatment interaction effect size was 1.04 (p = 0.3968).
SMHR
Adjusted mean %SMHR (± SE) at 2, 4 and 8 h for each den-
tifrice is shown in Fig. 3. At the 4-h time point (see Table 2),
there was no detectable increase in SMHR for the Test
dentifrice versus the Negative control or Reference dentifrice.
In contrast, the SMHR value for the Positive control dentifrice
was 8.63 percentage points higher than that of the Negative
control and was statistically significantly superior to all other
dentifrices (all p < 0.0001). The SMHR value for the
Reference dentifrice was slightly but significantly lower than
that for the Negative control (difference of −3.1%; p =
0.0160).
Similar differences and statistical significances were dem-
onstrated at 2 and 8 h post intra-oral exposure, except that no
statistically significant differences between the Reference den-
tifrice and the Negative control were seen at 8 h.
As for RER, there was a consistent upward trend for the
SMHR values as a function of time for all treatments. Again,
there was no indication that the rate of rise was a function of
treatment: the time-by-treatment interaction effect size was
0.84 (p = 0.5413).
Table 3 Treatment comparisons at 4 h post-treatment (mean difference with higher and lower confidence intervals)
Treatment
comparison
%RER %SMHR ARR EFU
Differencea (95% CI) p value
Test vs. Pos cont −26.67 (−31.10, −22.30) < 0.0001 −9.24 (−11.70, −6.74) < 0.0001 −0.17 (−0.21, −0.13) < 0.0001 −0.66 (−0.88, −0.45) < 0.0001
Test vs. Neg cont 18.42 (14.03, 22.82) < 0.0001 −0.61 (−3.12, 1.89) 0.6287 0.19 (0.15, 0.23) < 0.0001 0.93 (0.71, 1.15) < 0.0001
Test vs. Ref 2.17 (−2.24, 6.58) 0.3330 2.50 (−0.01, 5.01) 0.0509 0.00 (−0.04, 0.04) 0.8811 0.21 (−0.01, 0.43) 0.0574
Pos cont vs. Neg
cont
45.09 (40.69, 49.49) < 0.0001 8.63 (6.12, 11.13) < 0.0001 0.36 (0.32, 0.40) < 0.0001 1.59 (1.38, 1.81) < 0.0001
Pos cont vs. Ref 28.84 (24.40, 33.28) < 0.0001 11.74 (9.21, 14.27) < 0.0001 0.17 (0.13, 0.21) < 0.0001 0.88 (0.66, 1.09) < 0.0001
Ref vs. Neg cont 16.25 (11.81, 20.69) < 0.0001 −3.12 (−5.64, −0.59) 0.0160 0.19 (0.15, 0.23) < 0.0001 0.72 (0.50, 0.94) < 0.0001
RER, relative erosion resistance; SMHR, surface microhardness recovery; ARR, acid resistance ratio; EFU, enamel fluoride uptake; Pos cont, Positive
control; Neg cont, Negative control; Ref, Reference
Statistically significant comparisons are highlighted in bold
a Difference is first-named treatment minus second-named treatment; positive difference favours first-named treatment
Fig. 3 Percent surface
microhardness recovery
(%SMHR) versus specimen
removal time (adjusted means ±
standard error). Data for the
Negative Control and Test
dentifrices are offset for clarity
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ARR
The ARR values at 2, 4 and 8 h for each dentifrice treatment
are shown in Fig. 4. At the 4-h time point (see Table 3), there
was a difference of 0.19 in ARR between the Test dentifrice
and the Negative control (p < 0.0001) but there was no signif-
icant difference between the Test and Reference dentifrice.
The Positive control dentifrice gave statistically significantly
greater ARR compared to all other dentifrices (p < 0.0001 for
all), including a difference of 0.17 compared to the Test den-
tifrice. Similar differences and statistical significances were
also demonstrated at 2 and 8 h post intra-oral exposure.
The change in ARR value with time was found to be a
function of applied treatment: the time-by-treatment interac-
tion was statistically significant (at the 10% level generally
accepted for such interaction effects) with an effect size of
2.11 (p = 0.0506). This appeared to be driven particularly by
the ARR value for the Negative control, which was highest at
8 h, and the ARR value for the Positive control, which was
lowest at this time point.
EFU
Adjusted mean EFU at 2, 4 and 8 h for each dentifrice is
shown in Fig. 5. At the 4-h time point (see Table 2), the Test
dentifrice gave statistically significantly higher EFU than the
Negative control (p < 0.0001), but there was no significant
difference between the Test and Reference dentifrices. The
Positive control gave significantly higher EFU than all other
dentifrices (p < 0.0001 for all), and there was a significant
difference favouring the Reference dentifrice compared to
the Negative control (p < 0.0001).
Fig. 4 ARR, acid resistance ratio
versus specimen removal time
(adjusted means ± standard error).
Data for the Reference dentifrice
are offset for clarity
Fig. 5 Enamel fluoride uptake
versus specimen removal time
(adjusted means ± standard error).
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Similar differences and statistical significances were dem-
onstrated at 2 and 8 h post intra-oral exposure for most of the
comparisons except between the Test and Reference denti-
frices at 8 h, favouring the Test dentifrice (difference of 0.30
[95% CI 0.01, 0.59]; p = 0.0425).
In contrast to the RER and SMHR profiles, there was a
consistent downward trend for the EFU values as a function
of time, most clearly for the Positive control treatment.
However, there was no indication of a time-by-treatment in-
teraction for EFU (effect size of 0.54; p = 0.7766).
Safety
Treatment-emergent AEs were reported in eight subjects re-
ceiving the Test dentifrice (10 events, six of which were oral),
six subjects receiving the Positive control (six events, three
oral), two subjects receiving the Reference dentifrice (two
events, both oral) and six subjects receiving the Negative con-
trol (seven events, three oral). No AEs were considered treat-
ment-related, and no serious AEs occurred.
Discussion
This randomised, controlled clinical study used an in situ
enamel erosion model to explore the effects of phytate on
fluoride-mediated enamel rehardening of acid-softened enam-
el and subsequent protection against an acid challenge. This
model has been used previously to demonstrate that single
brushing with fluoride dentifrices can remineralise eroded
enamel and protect it against subsequent acid challenge
[6–8, 22, 25].
The use of bovine enamel as a surrogate for human enamel,
as in this study, has been reviewed by Lippert et al. [29].
Bovine enamel is advantageous in that it provides a large, flat
surface with uniform enamel thickness and it comes from a
source that has not been previously exposed to cariostatic
levels of fluoride, or a diet as varied as is common for human
teeth. Disadvantages of using bovine enamel include that there
are differences in porosity, carbonate and fluoride content sur-
face hardness, which mean that demineralisation progresses
more quickly than in human enamel [29]. However, a recent
study comparing fluoride dose–response of caries lesions in
bovine and human enamel found tha t a l though
demineralisation was higher in the former, the response to
fluoride was similar [30].
A limitation of this model is that it does not factor in the
impact of the dentifrice abrasive during application (as nor-
mally occurs with toothbrushing), or the potential impact of
other abrasive surfaces, such as the tongue. This is intention-
ally done to isolate the remineralising effects of the dentifrices
in the short-term period: this study was concerned with bio-
chemical effects of the dentifrice on enamel surfaces, rather
than physical effects. It is possible that mechanical contact
could wear away part of the demineralized enamel layer, not
allowing enough time for full fluoride remineralisation.
Further studies with modified in situ methodologies would
be required to understand the potential impact of physical
wear on remineralisation. Laboratory studies in which
abrasivity and fluoride concentration have been varied sys-
tematically have shown the ability of free fluoride ion to pro-
tect against abrasive wear from toothbrushing [31].
In the present study, the in situ model demonstrated the
expected effect of the Positive control fluoride dentifrice on
both promoting remineralisation (as measured by SMHR) and
protecting against subsequent demineralisation (as measured
by ARR) versus the fluoride-free Negative control. The RER
measure, which incorporates both remineralisation and
demineralisation in the calculation, was similarly supportive
of fluoride performance in this model.
However, this study showed that, using this model, incor-
porating phytate in a dentifrice (at 0.85% w/w hexasodium
salt) completely inhibited the remineralising effect of fluoride.
When phytate was present, fluoride uptake was also reduced,
but by nomeans eliminated, and the formulation still provided
significant protection against acid challenge. The retention of
this demineralisation-protective effect was sufficient to keep
the RER value for the experimental phytate product still great-
er than that of the fluoride-free control. The level of fluoride
uptake appears sufficient to explain the size of the
demineralisation-protective effect observed; there is little sug-
gestion in the data that the phytate is providing significant acid
protection. This result in an enamel erosion model does not
reflect the existing data from the enamel caries field, where—
in fluoride-free systems—phytate has been shown to be able
to inhibit enamel demineralisation and have potential anticar-
ies activity [18–20]. Further investigation is required to deter-
mine if phytate’s action at the enamel surface contributes to
protection from dietary acid attack.
Similar results were obtained with the Reference
pyrophosphate-containing formulation as seen with the Test
phytate formulation. Whilst there was a range of differences
between these two formulations that could influence
remineralisation–demineralisation effects to a degree, it is rea-
sonable to conclude that polyphosphates as a class, whether
linear or cyclic, can exert a substantially negative impact on
the remineralisation effect of fluoride ion in early enamel ero-
sive lesions. This effect has been observed for pyrophosphate
dentifrices in early enamel lesions in related in situ models [7,
16, 17]. It may be that any polyphosphate that can achieve
multi-point contact with a hydroxyapatite crystal structure can
inhibit mineral deposition into that structure from saliva.
The effect of intra-oral remineralisation time on the different
parameters was modest but nevertheless intriguing: whilst
remineralisation showed a clear upward trend through the
time-course of the treatment, as measured by SMHR, the
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amount of fluoride in the enamel appeared to slowly drop (for
the more effective treatments at least). That is, in this experi-
ment, fluoride levels in the enamel surface were strongly
boosted by the fluoride treatments but slowly decreased over
time. Such a trend has been seen previously in this model, when
enamel samples were removed from the in situ model between
5 min and 4 h after brushing with a fluoride dentifrice [23].
The observation that SMH increases whilst enamel fluoride
content decreases may illustrate the dynamic nature of the
enamel surface: ions at the surface can diffuse into and out
of the surface, according to the balance of concentration of the
ions in saliva and the affinity for those ions within the crystal
structure. The presence of high levels of fluoride in the enamel
surface after treatment will enhance the affinity of that surface
for calcium and phosphate ions in saliva [32], tending to drive
these ions into the surface, thereby increasing its SMH. Note
also that lesions exposed to the oral cavity under the condi-
tions of this model will naturally tend to remineralise on ex-
posure to saliva (as shown by the results for fluoride-free
control).
Most of the fluoride delivered into the oral cavity after
brushing with fluoride toothpaste remains unbound. It is
rapidly lost due to rinsing of oral surfaces, either with water
at the end of brushing, or by saliva in the minutes after-
wards: only a small fraction becomes bound to oral surfaces
[33]. Of the proportion directly taken up by enamel, the
majority will initially be in the form of non-specifically
adsorbed fluoride [34]. Some of this will be lost again
(washed away by saliva), and some will slowly convert to
fluoridated apatite [34]. CaF2 is not expected to form, as [F]
is too low and pH too high [35].
Furthermore, fluoride bound to soft tissues and plaque after
brushing will slowly be released into the oral fluids. This
fluoride will also promote enamel fluoride uptake and
remineralisation, before it too is washed away by the flow of
saliva. The observed outcome on SMH recovery and EFU is
the sum of this complex set of competing processes. Further
study of the time dependence of SMHR versus EFU is
warranted.
This in situ study provides intriguing insights into the
ability of fluoride dentifrices of different base formulations
to influence enamel remineralisation–demineralisation pro-
cesses after erosive attack, within the limitations of this in
situ methodology. The lesions studied were very early, re-
active erosive lesions: more established lesions may behave
differently. Only a single concentration of phytate was stud-
ied; other concentrations may exert contrasting effects on
intra-oral remineralisation and/or demineralisation.
Furthermore, the single-use protocol leaves unanswered
the question of what might happen to pre-eroded enamel
surfaces if the test products were used over a longer time-
period, with many cycles of erosive attack interleaved with
periods of remineralisation.
In summary, this single-use in situ study in early enamel
erosive lesions demonstrated that a dentifrice containing the
cyclic, organic polyphosphate ion phytate (at 0.85% w/w
hexasodium salt), in addition to 1150 ppm fluoride as NaF,
can exert positive effects on the remineralisation–
demineralisation processes at the surface of early enamel ero-
sive lesions as measured by RER. However, no benefits for
including phytate were detected: fluoride-induced
remineralisation was strongly inhibited, and there was no ev-
idence of an enamel protective benefit from phytate. Similar
results were obtained for a formulation containing the conven-
tional linear inorganic polyphosphate pyrophosphate and a
matched level of NaF.
The clinical implications of these findings are that formu-
lation ingredients can interfere with the enamel protective ef-
fects of fluoride. However, longer-term studies of the effects
of polyphosphates in dentifrices, incorporating multiple
remineralisation–demineralisation cycles, would be useful in
determining the longer-term consequences of the intra-oral
enamel surface chemistry observed in this study.
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